|1.||David, C S: 3 articles (11/2001 - 03/2000)|
|2.||David, Chella S: 2 articles (01/2014 - 01/2002)|
|3.||Lenner, P: 2 articles (10/2001 - 10/2000)|
|4.||Ghaderi, M: 2 articles (10/2001 - 10/2000)|
|5.||Dillner, J: 2 articles (10/2001 - 10/2000)|
|6.||Wiklund, F: 2 articles (10/2001 - 10/2000)|
|7.||Sanjeevi, C B: 2 articles (10/2001 - 10/2000)|
|8.||Hallmans, G: 2 articles (10/2001 - 10/2000)|
|9.||Casares, Sofia: 1 article (01/2014)|
|10.||Danner, Rebecca: 1 article (01/2014)|
10/01/2000 - "Our study suggests that the TNFa-11 allele is associated with HPV16 infection and associated with CIN in combination with HLA-DQ6 but not by itself."
10/01/2001 - "TNFa-11 was not associated with susceptibility to HPV16 infection, but it increased the risk for cervical cancer with the HLA DQ6 (DQA 1*0102-DQB 1*0602) haplotype. "
01/01/2014 - "In contrast, mice expressing HLA-DR4 (DR0402), HLA-DQ6 (DQ0601), HLA-DQ8 (DQ0302), or HLA-DR3 (DR0301) molecules in an EA(0) background were able to elicit specific antibodies and self-cure the infection. "
11/01/1996 - "The frequency of HLA-DQ6 was higher in asymptomatic DAT-positive blood donors (n = 8, 38% DQ6 positive, p = 0.48) than in DAT-positive hospital and clinic patients (n = 23, 13% DQ6 positive, corrected p value = 0.030, relative risk = 0.13, 95% Cl = 0.04-0.41), 96 percent of whom had evidence of clinical hemolysis. "
11/01/1996 - "This study demonstrates that HLA-DQ6 may have a negative association with a positive DAT result in patients with evidence for hemolysis, and may be a resistance antigen for clinically relevant red cell autoantibodies."
|3.||Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
06/01/2008 - "HLA-DQ6 (DQB1*0601)-restricted T cells protect against experimental autoimmune encephalomyelitis in HLA-DR3.DQ6 double-transgenic mice by generating anti-inflammatory IFN-gamma."
03/01/2000 - "To investigate the contribution of human leukocyte antigen (HLA) class II molecules in susceptibility to inflammatory demyelination, we induced experimental autoimmune encephalomyelitis (EAE) in transgenic (tg) mice expressing the HLA-DR3, HLA-DQ8 and HLA-DQ6 molecules in the absence of endogenous class II (Ab(o)). "
|4.||Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/01/1997 - "Analysis of critical residues of HLA-DQ6 molecules in insulin-dependent diabetes mellitus."
11/01/1997 - "HLA DQ8 (DQ A1*0301/DQB1*0302) molecule is implicated in the susceptibility to insulin dependent diabetes mellitus whereas, HLA DQ6 (DQ A1*0103/DQB1*0601) molecule may have a protective effect. "
|5.||Asthma (Bronchial Asthma)
10/15/2001 - "To determine the role and contribution of specific HLA class II in the pathogenesis of allergic airway inflammation in cockroach-induced asthma, we generated double-transgenic, double-knockout mice expressing human HLA-DQ8, HLA-DQ6, and CD4 molecules in the absence of mouse class II and mouse CD4. "
01/15/2002 - "To investigate the role of HLA-DQ molecules and/or CD4(+) T cells in the pathogenesis of allergic asthma, we generated HLA-DQ6 and HLA-DQ8 transgenic mice lacking endogenous class II (Abeta(null)) and CD4 genes and challenged them intranasally with short ragweed allergenic extract (SRW). "
|5.||HLA-DR3 Antigen (HLA DR3 Antigen)
|6.||HLA-DQ Antigens (HLA-DQ)
|7.||Acetylcholine (Acetylcholine Chloride)
|8.||Cytochromes c (Cytochrome c)